Pharmaceutical intermediates
Edoxaban tosylate monohydrate Intermediates
10 pharmaceutical intermediates for Edoxaban tosylate monohydrate. Indication: Pulmonary Embolism; Venous Thromboembolism; Stroke; Embolism; Venous Thrombosis.
About Edoxaban tosylate monohydrate
- Originator
- Daiichi Sankyo Co., Ltd
- Indication
- Pulmonary Embolism; Venous Thromboembolism; Stroke; Embolism; Venous Thrombosis
- Approved Date
- 01/08/2015
- DS/DP
- 04/18/2027
Available intermediates
10 intermediates currently listed for Edoxaban tosylate monohydrate. Request specifications, documentation or a quotation for any item below.
| Product Name | CAS No. | Molecular Formula | Physical Properties |
|---|---|---|---|
| (S)-cyclohex-3-enecarboxylic acid | 5708-19-0 | / | / |
| (1S,4S,5S)-4-bromo-6-oxabicyclo[3.2.1]octan-7-one | 139893-81-5 | / | / |
| 2-Bromo-5-methy1-4,5,6,7-tetrahydrothiazolo[5,4 -c]pyridine 4-methylbenzenesulfonate | 852291-42-0 | / | / |
| 2-Bromo-5-methy1-4,5,6,7-tetrahydrothiazolo[5,4 -c]pyridine | 143150-92-9 | / | / |
| N-(5-Chloropyridin-2-yl)oxalaMic acid ethyl ester | 349125-08-2 | / | / |
| tert-Butyl [(1R,2S,5S)-2-amino-5-[(dimethylamino)carbonyl]cyclohexyl]carbamate oxalate | 1210348-34-7 | / | / |
| tert-butyl (1R,2S,5S)-2-aMino-5-(diMethylcarbaMoyl)cyclohexylcarbaMate | 365998-36-3 | / | / |
| 5-Methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxylic acid hydrochloride | 720720-96-7 | / | / |
| 2-[(5-Chloropyridin-2-yl)amino]-2-oxoacetic acid ethyl ester monohydrochloride | 1243308-37-3 | / | / |
| Edoxaban tosylate monohydrate | 1229194-11-9 | / | / |
Building toward Edoxaban tosylate monohydrate?
Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →